Deepak L Bhatt - JoVE Visualize

Showing results (1211-1220 of 1,708) with videos related to

Pageof 171

Sort By:

JACC. Heart Failure|November 8, 2025

Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyZainali Chunawala, Kershaw V Patel, Katelyn R Garcia, et al.

Circulation. Cardiovascular Quality and Outcomes|August 16, 2019

Intravenous Tissue Plasminogen Activator in Stroke MimicsFatima Ali-Ahmed, Jerome J Federspiel, Li Liang, et al.

JAMA Network Open|July 28, 2022

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic StrokeYing Xian, Haolin Xu, Roland Matsouaka, et al.

Journal of Palliative Care|November 14, 2022

Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United StatesMuhammad Rashid, Haider J Warriach, Claire Lawson, et al.

European Heart Journal. Digital Health|March 19, 2026

Artificial intelligence-based automated interpretation of images of electrocardiograms: development and multinational validation of ECG-GPTAkshay Khunte, Veer Sangha, Evangelos K Oikonomou, et al.

Journal of Hypertension|December 20, 2013

Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular riskFadi Seif, Sanjay R Patel, Harneet K Walia, et al.

Journal of the American Heart Association|August 23, 2025

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES TrialGregory P Geba, Kusha A Mohammadi, Amy Damask, et al.

European Heart Journal|August 4, 2007

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trialThomas H Wang, Deepak L Bhatt, Keith A A Fox, et al.

Circulation|August 7, 2015

Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) StudyEmily C O'Brien, Melissa A Greiner, Ying Xian, et al.

JACC. Cardiovascular Interventions|February 24, 2015

Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])Harvey D White, Deepak L Bhatt, C Michael Gibson, et al.

Pageof 171

Showing results (1211-1220 of 1,708) with videos related to

Sort By:

Pageof 171

JACC. Heart Failure|November 8, 2025

Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyZainali Chunawala, Kershaw V Patel, Katelyn R Garcia, et al.

Circulation. Cardiovascular Quality and Outcomes|August 16, 2019

Intravenous Tissue Plasminogen Activator in Stroke MimicsFatima Ali-Ahmed, Jerome J Federspiel, Li Liang, et al.

JAMA Network Open|July 28, 2022

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic StrokeYing Xian, Haolin Xu, Roland Matsouaka, et al.

Journal of Palliative Care|November 14, 2022

Palliative Care Utilization Among Hospitalized Patients With Common Chronic Conditions in the United StatesMuhammad Rashid, Haider J Warriach, Claire Lawson, et al.

European Heart Journal. Digital Health|March 19, 2026

Artificial intelligence-based automated interpretation of images of electrocardiograms: development and multinational validation of ECG-GPTAkshay Khunte, Veer Sangha, Evangelos K Oikonomou, et al.

Journal of Hypertension|December 20, 2013

Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular riskFadi Seif, Sanjay R Patel, Harneet K Walia, et al.

Journal of the American Heart Association|August 23, 2025

Effect of PCSK9 Inhibition With Alirocumab in Patients With Probable Familial Hypercholesterolemia or Type III Hyperlipoproteinemia: Results From the ODYSSEY OUTCOMES TrialGregory P Geba, Kusha A Mohammadi, Amy Damask, et al.

European Heart Journal|August 4, 2007

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trialThomas H Wang, Deepak L Bhatt, Keith A A Fox, et al.

Circulation|August 7, 2015

Clinical Effectiveness of Statin Therapy After Ischemic Stroke: Primary Results From the Statin Therapeutic Area of the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) StudyEmily C O'Brien, Melissa A Greiner, Ying Xian, et al.

JACC. Cardiovascular Interventions|February 24, 2015

Outcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI])Harvey D White, Deepak L Bhatt, C Michael Gibson, et al.

Pageof 171